Headquartered in Saint Louis, MO Fiscal year ends December NYSE: CNC centene.com
Centene Corporation is a Fortune 500 healthcare enterprise that provides fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, with a focus on under-insured and underserved populations. The company serves more than 1 in 15 individuals across the United States through its Medicaid managed care plans, Medicare Advantage and Medicare Prescription Drug Plans (PDP), Health Insurance Marketplace (individual exchange) products, and commercial group health insurance offerings. Centene operates with a localized approach, deploying regional teams to manage healthcare delivery and cost across its membership base of approximately 25.9 million at-risk members. The company's business is organized into Medicaid, Commercial, Medicare, and Other segments, with Medicaid being the largest by premium revenue. Centene also manages specialty services and state-directed payment programs as part of its integrated care model. Updated
On October 4, Suze Orman, the personal finance author and former CNBC host, had a warning for her podcast listeners covered by UnitedHealth Group (NYSE:UNH | UNH Price Prediction): “If you have…
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a…
Pre-Market Stock Futures: Futures are trading lower after a mixed start to trading on Monday, following the holiday-shortened week due to the Juneteenth Federal holiday. We may start to see some end-of-the-quarter…
Pre-Market Stock Futures: Futures are trading higher on the heels of the third straight day of stock declines, and there is growing apprehension that yields will go even higher and that inflation…
When Centene Corporation reported its first-quarter results in late April, the numbers told two stories that seemed impossible to reconcile. The St. Louis-based insurer had hemorrhaged customers, watching its Affordable Care Act…
Don Lair Shares of Centene Corporation (NYSE: CNC | CNC Price Prediction) have climbed 6.2% from their November 10 low of $34.25. Today, shares closed at $36.38. The move coincides with sustained bullish sentiment…
Douglas A. McIntyre Is OSCR in Good Health? Oscar Health (NYSE:OSCR) is a technology-driven health insurance company specializing in individual, family, and small group plans, primarily through Affordable Care Act (ACA) exchanges. Its platform leverages…
The abrupt departure of UnitedHealth (NYSE:UNH) CEO Andrew Witty this week has sent shockwaves through an already tumultuous healthcare sector. Investors in UNH stock have certainly had plenty of headwinds to deal with over…
Michael Burry is best-known as the billionaire investor who correctly predicted the housing market crash in 2007 that was detailed in the book, The Big Short. It was subsequently made into a…
Analysts' first ratings changes for 2024 include some deletions from a top buy list and a downgrade for Apple.
Wednesday's top analyst upgrades and downgrades included American Express, Catalent, Centene, Lowe's Companies, NetApp, Shoals Technologies, Valley National Bancorp and ZoomInfo Technologies.
Thursday's top analyst upgrades and downgrades included Best Buy, Carnival, Caterpillar, Centene, ChargePoint, Foot Locker, Hewlett Packard Enterprise, Palo Alto Networks, PDD, Peloton Interactive, Realty Income, Sunrun, Texas Instruments and UDR.
Wednesday's top analyst upgrades and downgrades included Allstate, Archer Daniels Midland, Avis Budget, Baidu, Centene, Lemonade, Melco Resorts & Entertainment, Palantir Technologies, Peabody Energy, Philip Morris, Shopify and Zscaler.
Here are our previews of BP, Centene, Linde, which will report earnings before U.S. markets open on Tuesday.
Tuesday's top analyst upgrades and downgrades included AT&T, Baxter International, Centene, Darden Restaurants, Lennar, L3 Harris Technologies, MGM Resorts International, Nvidia and Vertex Pharmaceuticals.
Centene Corporation is a Fortune 500 healthcare enterprise that provides fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, with a focus on under-insured and underserved populations.
The Wall Street consensus 12-month price target for CNC is $71.78. CNC price prediction →
